Patients with glioblastoma can expect to live a median eight months after diagnosis, but two anticipated launches in 2024 and a rich development pipeline could improve that bleak clinical outlook.
“There’s never been so much cause for hope. The standard of care hasn’t changed for 25 years,” Will Jones, chief...